Get the Stockscreener App
9.694
0.88%
0.144
Integra Lifesciences Holdings Corp stock is traded at $9.694, with a volume of 13,950.
It is up +0.88% in the last 24 hours and down -14.97% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
See More
Previous Close:
$9.55
Open:
$9.52
24h Volume:
13,950
Relative Volume:
0.02
Market Cap:
$755.99M
Revenue:
$1.64B
Net Income/Loss:
$-516.47M
P/E Ratio:
-1.4394
EPS:
-6.7348
Net Cash Flow:
$-45.25M
1W Performance:
+8.25%
1M Performance:
-14.97%
6M Performance:
-27.02%
1Y Performance:
-55.85%
1-Day Range:
$9.415
$9.71
1-Week Range:
$8.70
$9.75
52-Week Range:
$8.70
$22.27
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
9.70 | 744.30M | 1.64B | -516.47M | -45.25M | -6.7348 |
ABT
Abbott Laboratories
|
104.97 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.95 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.65 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
70.19 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.23 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
IART SEC FilingsIntegra Lifesciences Hldgs Cp 10-K, 10-Q, 8-K Forms - Stock Titan
Risk Analysis: Can Integra LifeSciences Holdings Corporation generate free cash flowMarket Growth Summary & Long-Term Growth Plans - baoquankhu1.vn
Integra LifeSciences (NASDAQ:IART) Market Dynamics Track Nasdaq Index - Kalkine Media
Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance
Integra Lifesciences (IART) EVP reports major RSU grant and vesting - Stock Titan
Integra (IART) EVP receives 92,108 RSUs and surrenders shares for taxes - Stock Titan
Integra (NASDAQ: IART) EVP gets 43,350 RSUs, shares withheld for tax - Stock Titan
Integra Lifesciences (IART) SVP granted 15,957 RSUs with 1,147 shares withheld for taxes - Stock Titan
Integra (IART) CFO granted 111,179 RSUs; 8,089 shares withheld for tax - Stock Titan
Integra Lifesciences (IART) EVP gets 41,783 RSUs, 5,420 shares for tax - Stock Titan
Integra (IART) CEO granted 343,393 restricted stock units as deferred pay - Stock Titan
Integra Lifesciences (IART) CLO granted 70,305 restricted stock units - Stock Titan
Citigroup Maintains Sell Rating on IART and Lowers Price Target - GuruFocus
IART (Integra Lifesciences Holdings) NonCurrent Deferred Re - GuruFocus
IART Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Integra LifeSciences (NASDAQ:IART) Downgraded to “Hold” Rating by Wall Street Zen - Defense World
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings is Now Oversold (IART) - Nasdaq
Integra LifeSciences Holdings Corp. Sees Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
IART Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Integra LifeSciences Hits 52-Week Low at $10.36 Amidst Ongoing Struggles - Markets Mojo
Integra LifeSciences Opens Weak with 8.37% Gap Down Amid Market Concerns - Markets Mojo
Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.7% Following Analyst Downgrade - MarketBeat
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Integra Lifesciences (IART) Analyst Rating Update: Wells Fargo L - GuruFocus
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - MarketBeat
US med-tech companies bullish about 2026 - BioWorld MedTech
Stocks making big moves this week: Flywire, First Advantage, Integra LifeSciences, Huron, and Montrose - Yahoo Finance
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month LowWhat's Next? - MarketBeat
Integra Lifesciences Holdings Corp (IART) Q4 2025 Earnings Call - GuruFocus
Integra LifeSciences Q4 Earnings Call Highlights - Yahoo Finance
Integra LifeSciences (IART) Stock Trades Down, Here Is Why - Finviz
Integra LifeSciences (NASDAQ:IART) Shares Gap DownWhat's Next? - MarketBeat
Earnings call transcript: Integra LifeSciences beats Q4 2025 EPS forecast - Investing.com
Integra LifeSciences (NASDAQ:IART) Surprises With Q4 CY2025 Sales - Finviz
Q4 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Q4 25 Earnings Conference Call At 8:30 AM ET - Nasdaq
Integra LifeSciences (IART) Anticipates Lower Q1 Revenue Than Ex - GuruFocus
INTEGRA LIFESCIENCES HLDGS ($IART) Releases Q4 2025 Earnings - Quiver Quantitative
Integra LifeSciences beats estimates but guides below consensus By Investing.com - Investing.com South Africa
Integra LifeSciences beats estimates but guides below consensus - Investing.com
Integra: Q4 Earnings Snapshot - marketscreener.com
Integra LifeSciences Reports Q4 Loss, Revenue Edges Down - Nasdaq
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Integra LifeSciences Reports Q4 and Full Year 2025 Financial Results with Operational Progress and 2026 Financial Guidance - Quiver Quantitative
Goodwill hit drives 2025 loss at Integra LifeSciences (NASDAQ: IART) - Stock Titan
Integra takes $511M hit from tariffs, quality and supply issues - Stock Titan
Integra Lifesciences Holdings Corp (IART) Q4 2025 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
0.00%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):